P. Ö. ŞİMŞEK KİPER, "Deficiency of SFRP4, a soluble LRP receptor antagonist, impairs the formation of cortical bone and results in Pyle Disease.," International Skeletal Dysplasia Society Meeting , 2017
ŞİMŞEK KİPER, P. Ö. 2017. Deficiency of SFRP4, a soluble LRP receptor antagonist, impairs the formation of cortical bone and results in Pyle Disease.. International Skeletal Dysplasia Society Meeting .
ŞİMŞEK KİPER, P. Ö., (2017). Deficiency of SFRP4, a soluble LRP receptor antagonist, impairs the formation of cortical bone and results in Pyle Disease. . International Skeletal Dysplasia Society Meeting
ŞİMŞEK KİPER, PELİN. "Deficiency of SFRP4, a soluble LRP receptor antagonist, impairs the formation of cortical bone and results in Pyle Disease.," International Skeletal Dysplasia Society Meeting, 2017
ŞİMŞEK KİPER, PELİN Ö. . "Deficiency of SFRP4, a soluble LRP receptor antagonist, impairs the formation of cortical bone and results in Pyle Disease.." International Skeletal Dysplasia Society Meeting , 2017
ŞİMŞEK KİPER, P. Ö. (2017) . "Deficiency of SFRP4, a soluble LRP receptor antagonist, impairs the formation of cortical bone and results in Pyle Disease.." International Skeletal Dysplasia Society Meeting .
@conferencepaper{conferencepaper, author={PELİN ÖZLEM ŞİMŞEK KİPER}, title={Deficiency of SFRP4, a soluble LRP receptor antagonist, impairs the formation of cortical bone and results in Pyle Disease.}, congress name={International Skeletal Dysplasia Society Meeting}, city={}, country={}, year={2017}}